Does a CGM tell non-diabetics anything useful about recovery?

What a CGM actually measures, and what "normal" looks like

A CGM — most commonly a Dexcom or Abbott Freestyle Libre sensor worn on the arm — measures glucose in the interstitial fluid under the skin every few minutes, not glucose in your blood directly. It's a genuinely useful, FDA-cleared technology for people who need to manage insulin dosing. The open question is what it adds once someone's fasting glucose and HbA1c are already in the normal range.

A 2024 analysis of the Framingham Heart Study cohort gives the clearest published picture of what "normal" looks like on a CGM in people without diabetes:

Two things stand out. First, the reference band this study used (70-140 mg/dL) is narrower than the standard 70-180 mg/dL clinical target used for people who already have diabetes — so don't cross-apply the diabetes target to your own non-diabetic readings, they're not the same yardstick. Second, and more important for the "should I worry about this spike" question: people with completely normal fasting glucose and A1c routinely spend a few hours a day above 140 mg/dL after meals. That's the expected pattern, not a warning sign.

Even "normal" people vary a lot from each other

A widely cited Stanford study that coined the term "glucotypes" put continuous monitors on 57 people who were not diabetic by standard testing and found their glucose responses to identical meals fell into distinct patterns — some people ran consistently low-variability, others showed pronounced spikes to the same food, independent of their fasting glucose or A1c classification. The researchers' point wasn't that some of these people were secretly unhealthy; it was that a single fasting blood draw and A1c value compress a lot of real, individual variation in how bodies handle glucose, and a CGM can reveal that individual pattern in a way a one-time blood test can't.

That's the genuinely useful part of the technology for a healthy person: it's a personalized lens on how your specific meals, portions, and timing behave, compared with population averages. It is not, on current evidence, a screening tool that tells you something is medically wrong.

The recovery/HRV claim specifically: what's tested and what isn't

This is where marketing for consumer CGM apps tends to get ahead of the research. It's worth separating two claims that sound similar but rest on completely different evidence:

1. "Chronic glycemic control is linked to autonomic nervous system function." This one has real support. A study of 146 healthy adults (the Leipzig Study for Mind-Body-Emotion Interactions) found that HbA1c — the three-month average of blood glucose — was inversely correlated with resting HRV: people with slightly higher average glucose over months tended to have lower HRV. This is a slow-moving, population-level association between chronic metabolic health and autonomic tone.

2. "A glucose spike from today's meal will show up as a lower HRV or recovery score tomorrow morning." This is the claim consumer CGM-plus-wearable marketing implies, and it has essentially no direct published evidence in healthy adults. Nobody has run the study that puts a CGM and an overnight HRV-tracking wearable on the same non-diabetic people and shown that a bigger daytime spike predicts a worse night. The nearest related research — on whether a post-meal walk's glucose benefit carries into overnight recovery — actually found the opposite in one well-controlled trial: the glucose improvement didn't persist into the overnight period in healthy adults.

Claim 1 is a real, if modest and slow, relationship. Claim 2 — the specific, actionable-sounding version that sells CGM subscriptions — is an inference nobody has tested. Don't let the credibility of the first borrow itself onto the second.

Why the CGM-HbA1c relationship itself falls apart in healthy people

A 2025 study from Mass General Brigham, published in Diabetes Technology & Therapeutics, put a Dexcom G6 on 972 adults for up to 10 days and compared CGM-derived metrics against each person's HbA1c. In the 43.3% of the cohort with type 2 diabetes, CGM average glucose tracked HbA1c closely, as expected. In the 32.8% with prediabetes, the relationship weakened substantially (mean glucose showed only a moderate standardized association). In the 23.9% with normal blood sugar, CGM metrics were largely unrelated to HbA1c.

That finding matters beyond the recovery-score question: it means the whole logic of "my CGM average will validate what my last blood panel showed" doesn't really hold once you're already metabolically healthy. The CGM is capturing something real — short-term variability — that a three-month average was never built to reflect at that resolution, and the two measurements simply diverge in that population.

Systematic reviews of CGM use for cardiovascular-prevention purposes in non-diabetic adults reach a similar conclusion from a different angle: there's no randomized controlled trial showing CGM use changes hard outcomes (cardiovascular events, diabetes incidence, mortality) in this population compared with standard dietary counseling, and even the evidence for improving intermediate measures like body weight or cardiovascular risk factors is limited and inconsistent.

A reasonable way to use one anyway, if you want to

None of this means a CGM is useless for a healthy person — it means the honest use case is narrower than the marketing suggests.

1. Treat it as a single, time-boxed experiment, not an ongoing monitor. Most sensors last 10-14 days; that's plenty to learn your own pattern for a handful of typical meals.
2. Compare yourself to yourself, not to a population "normal." The glucotypes research shows healthy people vary meaningfully from each other — your own before/after on a specific meal change is more informative than a generic reference range.
3. Don't overweight a single spike. A few hours above 140 mg/dL after a carb-heavy meal is the expected pattern in people without diabetes, based on the Framingham data above, not evidence of a problem.
4. Keep the recovery question separate. If you also track recovery and HRV, you can informally log your own glucose pattern next to your own overnight numbers for a few weeks — that's a legitimate personal experiment. Just don't assume the published research already validated the connection for you; it hasn't yet.
5. If you actually want to know your metabolic risk, a fasting glucose, HbA1c, and lipid panel read by a clinician remains the validated route — not a CGM trend line. Uploading that kind of lab report and asking follow-up questions is a more evidence-backed way to get a read on where you stand than interpreting CGM squiggles in isolation.

The bottom line

A CGM is a precise, well-validated tool for a group of people who genuinely need it — anyone managing diabetes. For someone without diabetes or prediabetes, it mostly tells you something you already knew (carb-heavy meals raise glucose for a couple of hours) with more granularity than you need, and the specific claim that a daytime spike will degrade your overnight HRV or recovery score isn't something the research has tested, let alone confirmed. If you want to experiment with one, do it as a short personal curiosity project rather than a diagnostic tool, and keep your metabolic-risk questions pointed at your doctor and a real blood panel instead of a glucose trend line. If a pattern in your own data genuinely puzzles you, that's also a reasonable thing to bring up in an AI coach conversation alongside your recovery and sleep trends — treated as a personal observation to investigate, not a conclusion the science has already reached for you.